| Overview |
| bsm-90342r-50µL |
| Cyclin dependent kinase inhibitor 1B Recombinant Antbody Kit (KD-Validated) |
| WB, FCM, IC |
| Knockdown Validated |
| Human, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human p27 KIP 1 |
| 150-198/198 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 1027 |
| P46527 |
| CDKN1B; Cyclin Dependent Kinase Inhibitor 1B; KIP1; P27KIP1; Cyclin-Dependent Kinase Inhibitor 1B (P27 Kip1); Cyclin-Dependent Kinase Inhibitor 1B; Cyclin-Dependent Kinase Inhibitor P27; P27Kip1; CDKN4; MEN1B; MEN4; P27 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| FCM |
1:20-100 |
| IC |
1:1000 |
Powered by Bioz